Photocure ASA
Photocure ASA, together with its subsidiaries, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products. It operates through Commercial Franchise and Development Portfolio segments. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus-induced ce… Read more
Market Cap & Net Worth: Photocure ASA (PHCUF)
Photocure ASA (PINK:PHCUF) has a market capitalization of $114.94 Million ($114.94 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #18839 globally and #6977 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Photocure ASA's stock price $4.32 by its total outstanding shares 26606672 (26.61 Million).
Photocure ASA Market Cap History: 2015 to 2025
Photocure ASA's market capitalization history from 2015 to 2025. Data shows growth from $122.39 Million to $114.94 Million (0.43% CAGR).
Photocure ASA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Photocure ASA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.23x
Photocure ASA's market cap is 0.23 times its annual revenue
1.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $122.39 Million | $134.72 Million | -$36.18 Million | 0.91x | N/A |
| 2016 | $131.70 Million | $143.63 Million | $35.31 Million | 0.92x | 3.73x |
| 2017 | $81.15 Million | $150.91 Million | -$34.70 Million | 0.54x | N/A |
| 2018 | $142.35 Million | $181.51 Million | -$36.71 Million | 0.78x | N/A |
| 2019 | $270.06 Million | $281.56 Million | $31.83 Million | 0.96x | 8.48x |
| 2020 | $295.02 Million | $256.48 Million | -$22.40 Million | 1.15x | N/A |
| 2021 | $325.93 Million | $360.54 Million | -$30.90 Million | 0.90x | N/A |
| 2022 | $286.82 Million | $393.13 Million | -$71.86 Million | 0.73x | N/A |
| 2023 | $162.30 Million | $500.66 Million | $979.00K | 0.32x | 165.78x |
| 2024 | $119.20 Million | $525.39 Million | -$4.81 Million | 0.23x | N/A |
Competitor Companies of PHCUF by Market Capitalization
Companies near Photocure ASA in the global market cap rankings as of March 18, 2026.
Key companies related to Photocure ASA by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #423 globally with a market cap of $51.97 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #455 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #423 | Zoetis Inc | NYSE:ZTS | $51.97 Billion | $118.15 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.46 |
| #455 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Photocure ASA Historical Marketcap From 2015 to 2025
Between 2015 and today, Photocure ASA's market cap moved from $122.39 Million to $ 114.94 Million, with a yearly change of 0.43%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $114.94 Million | -3.57% |
| 2024 | $119.20 Million | -26.56% |
| 2023 | $162.30 Million | -43.41% |
| 2022 | $286.82 Million | -12.00% |
| 2021 | $325.93 Million | +10.48% |
| 2020 | $295.02 Million | +9.24% |
| 2019 | $270.06 Million | +89.72% |
| 2018 | $142.35 Million | +75.41% |
| 2017 | $81.15 Million | -38.38% |
| 2016 | $131.70 Million | +7.61% |
| 2015 | $122.39 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Photocure ASA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $114.94 Million USD |
| MoneyControl | $114.94 Million USD |
| MarketWatch | $114.94 Million USD |
| marketcap.company | $114.94 Million USD |
| Reuters | $114.94 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.